Factors affecting the degree of QT prolongation with drug challenge in a large cohort of normal volunteers

Heart Rhythm

Volumn 8, Issue 10, 2011, Pages 1530-1534

  Kannankeril, Prince J ^a   Norris, Kris J ^b   Carter, Shannon ^b   Roden, Dan M ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Electrocardiography; Ion channels; Obesity; Pharmacology; QT interval

Indexed keywords

IBUTILIDE;

ADULT; ARTICLE; BODY MASS; FEMALE; HEART ARRHYTHMIA; HUMAN; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SEX DIFFERENCE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; CHI-SQUARE DISTRIBUTION; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; SULFONAMIDES;

EID: 80053050729     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.03.042     Document Type: Article

References (27)

1. D.M. Roden Long QT syndrome: reduced repolarization reserve and the genetic link J Intern Med 259 2006 59 69
2. W.M. Jackman, K.J. Friday, and J.L. Anderson The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis Prog Cardiovasc Dis 31 1988 115 172
3. P.J. Kannankeril, and D.M. Roden Drug-induced long QT and torsade de pointes: recent advances Curr Opin Cardiol 22 2007 39 43 (Pubitemid 44901054)
4. D.M. Roden Drug-induced prolongation of the QT interval N Engl J Med 350 2004 1013 1022 (Pubitemid 38269278)
5. D.J. Whellan, C.L. Green, J.P. Piccini, and M.W. Krucoff QT as a safety biomarker in drug development Clin Pharmacol Ther 86 2009 101 104
6. R.R. Makkar, B.S. Fromm, R.T. Steinman, M.D. Meissner, and M.H. Lehmann Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs JAMA 270 1993 2590 2597 (Pubitemid 23346699)
7. D. Zeltser, D. Justo, and A. Halkin Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors Medicine (Baltimore) 82 2003 282 290 (Pubitemid 36859224)
8. Kr Implications for torsade de pointes and reverse use-dependence Circulation 93 1996 407 411
9. D.M. Roden, R.L. Woosley, and R.K. Primm Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care Am Heart J 111 1986 1088 1093 (Pubitemid 16085013)
10. D. Darbar, M.F. Fromm, S. Dellorto, and D.M. Roden Sympathetic activation enhances QT prolongation by quinidine J Cardiovasc Electrophysiol 12 2001 9 14 (Pubitemid 32099477)
11. K.T. Murray Ibutilide Circulation 97 1998 493 497 (Pubitemid 28091075)
12. P.G. Postema, J.S. De Jong, I. Van dB, and A.A. Wilde Accurate electrocardiographic assessment of the QT interval: teach the tangent Heart Rhythm 5 2008 1015 1018
13. E. Lepeschkin, and B. Surawicz The measurement of the Q-T interval of the electrocardiogram Circulation 6 1952 378 388
14. C.L. Ogden, M.D. Carroll, and L.R. Curtin Prevalence of overweight and obesity in the United States, 19992004 JAMA 295 2006 1549 1555
15. K.P. Letsas, M. Efremidis, and S.P. Kounas Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors Clin Res Cardiol 98 2009 208 212
16. D. Darbar, J. Kimbrough, and A. Jawaid Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome J Am Coll Cardiol 51 2008 836 842 (Pubitemid 351253747)
17. S. Kaab, M. Hinterseer, M. Nabauer, and G. Steinbeck Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome: a case-control pilot study using i.v. sotalol Eur Heart J 24 2003 649 657 (Pubitemid 36343198)
18. M.H. Lehmann, S. Hardy, D. Archibald, and D.J. MacNeil JTc prolongation with d,l-sotalol in women versus men Am J Cardiol 83 1999 354 359 (Pubitemid 29066493)
19. S.A. Vardar, L. Ozturk, A. Altun, and N. Turan Ventricular repolarization in overweight and normal weight healthy young men Anadolu Kardiyol Derg 8 2008 27 31 (Pubitemid 351266063)
20. A. el-Gamal, D. Gallagher, and A. Nawras Effects of obesity on QT, RR, and QTc intervals Am J Cardiol 75 1995 956 959
21. A.H. Ramirez, J.S. Schildcrout, and D.L. Blakemore Modulators of normal electrocardiographic intervals identified in a large electronic medical record Heart Rhythm 8 2011 271 277
22. G.M. Corbi, S. Carbone, and P. Ziccardi FFAs and QT intervals in obese women with visceral adiposity: effects of sustained weight loss over 1 year J Clin Endocrinol Metab 87 2002 2080 2083 (Pubitemid 34521491)
23. R. Marfella, L. De Angelis, and F. Nappo Elevated plasma fatty acid concentrations prolong cardiac repolarization in healthy subjects Am J Clin Nutr 73 2001 27 30 (Pubitemid 32016811)
24. K. Esposito, G. Nicoletti, and S. Marzano Autonomic dysfunction associates with prolongation of QT intervals and blunted night BP in obese women with visceral obesity J Endocrinol Invest 25 2002 RC32 RC35
25. A.H. Smith, K.J. Norris, D.M. Roden, and P.J. Kannankeril Autonomic tone attenuates drug-induced QT prolongation J Cardiovasc Electrophysiol 18 2007 960 964 (Pubitemid 47339052)
26. A. Papaioannou, D. Michaloudis, and O. Fraidakis Effects of weight loss on QT interval in morbidly obese patients Obes Surg 13 2003 869 873 (Pubitemid 38010707)
27. D.M. Roden, P. Kannankeril, and D. Darbar On the relationship among QT interval, atrial fibrillation, and torsade de pointes Europace 9 Suppl 4 2007 iv1 iv3